125 related articles for article (PubMed ID: 38576392)
21. A Super-SILAC Strategy for the Accurate and Multiplexed Profiling of Histone Posttranslational Modifications.
Noberini R; Bonaldi T
Methods Enzymol; 2017; 586():311-332. PubMed ID: 28137569
[TBL] [Abstract][Full Text] [Related]
22. Proteomic Analysis Revealed the Potential Role of MAGE-D2 in the Therapeutic Targeting of Triple-Negative Breast Cancer.
Shi X; Liu C; Zheng W; Cao X; Li W; Zhang D; Zhu J; Zhang X; Chen Y
Mol Cell Proteomics; 2024 Jan; 23(1):100703. PubMed ID: 38128647
[TBL] [Abstract][Full Text] [Related]
23. Global assessment of combinatorial post-translational modification of core histones in yeast using contemporary mass spectrometry. LYS4 trimethylation correlates with degree of acetylation on the same H3 tail.
Jiang L; Smith JN; Anderson SL; Ma P; Mizzen CA; Kelleher NL
J Biol Chem; 2007 Sep; 282(38):27923-34. PubMed ID: 17652096
[TBL] [Abstract][Full Text] [Related]
24. Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer.
Quintero M; Adamoski D; Reis LMD; Ascenção CFR; Oliveira KRS; Gonçalves KA; Dias MM; Carazzolle MF; Dias SMG
BMC Cancer; 2017 Nov; 17(1):727. PubMed ID: 29115931
[TBL] [Abstract][Full Text] [Related]
25. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
[TBL] [Abstract][Full Text] [Related]
26. Top-down and Middle-down Protein Analysis Reveals that Intact and Clipped Human Histones Differ in Post-translational Modification Patterns.
Tvardovskiy A; Wrzesinski K; Sidoli S; Fey SJ; Rogowska-Wrzesinska A; Jensen ON
Mol Cell Proteomics; 2015 Dec; 14(12):3142-53. PubMed ID: 26424599
[TBL] [Abstract][Full Text] [Related]
27. An Integrated Approach Based on a DNA Self-Assembly Technique for Characterization of Crosstalk among Combinatorial Histone Modifications.
Bai X; Bi W; Dong H; Chen P; Tian S; Zhai G; Zhang K
Anal Chem; 2018 Mar; 90(6):3692-3696. PubMed ID: 29465975
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in mass spectrometry analysis of histone post-translational modifications: potential clinical impact of the PAT-H-MS approach.
Bonaldi T; Noberini R
Expert Rev Proteomics; 2016; 13(3):245-50. PubMed ID: 26822344
[TBL] [Abstract][Full Text] [Related]
29. Quantitative proteomics reveals stage-specific protein regulation of triple negative breast cancer.
Lin Y; Lin L; Fu F; Wang C; Hu A; Xie J; Jiang M; Wang Z; Yang L; Guo R; Yang P; Shen H
Breast Cancer Res Treat; 2021 Jan; 185(1):39-52. PubMed ID: 32920739
[TBL] [Abstract][Full Text] [Related]
30. Histone post-translational modifications induced by histone deacetylase inhibition in transcriptional control units of NIS gene.
Baldan F; Lavarone E; Di Loreto C; Filetti S; Russo D; Damante G; Puppin C
Mol Biol Rep; 2014 Aug; 41(8):5257-65. PubMed ID: 24844212
[TBL] [Abstract][Full Text] [Related]
31. Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach.
Noberini R; Pruneri G; Minucci S; Bonaldi T
Data Brief; 2016 Jun; 7():188-94. PubMed ID: 27408908
[TBL] [Abstract][Full Text] [Related]
32. Quantitative mass spectrometry of histones H3.2 and H3.3 in Suz12-deficient mouse embryonic stem cells reveals distinct, dynamic post-translational modifications at Lys-27 and Lys-36.
Jung HR; Pasini D; Helin K; Jensen ON
Mol Cell Proteomics; 2010 May; 9(5):838-50. PubMed ID: 20150217
[TBL] [Abstract][Full Text] [Related]
33. Chromatin complexes subunit BAP18 promotes triple-negative breast cancer progression through transcriptional activation of oncogene S100A9.
Zhang YL; Deng L; Liao L; Yang SY; Hu SY; Ning Y; Zhang FL; Li DQ
Cell Death Dis; 2022 Apr; 13(4):408. PubMed ID: 35484101
[TBL] [Abstract][Full Text] [Related]
34. Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways.
Wu X; Zahari MS; Ma B; Liu R; Renuse S; Sahasrabuddhe NA; Chen L; Chaerkady R; Kim MS; Zhong J; Jelinek C; Barbhuiya MA; Leal-Rojas P; Yang Y; Kashyap MK; Marimuthu A; Ling M; Fackler MJ; Merino V; Zhang Z; Zahnow CA; Gabrielson E; Stearns V; Roa JC; Sukumar S; Gill PS; Pandey A
Oncotarget; 2015 Oct; 6(30):29143-60. PubMed ID: 26356563
[TBL] [Abstract][Full Text] [Related]
35. Systems Level Analysis of Histone H3 Post-translational Modifications (PTMs) Reveals Features of PTM Crosstalk in Chromatin Regulation.
Schwämmle V; Sidoli S; Ruminowicz C; Wu X; Lee CF; Helin K; Jensen ON
Mol Cell Proteomics; 2016 Aug; 15(8):2715-29. PubMed ID: 27302890
[TBL] [Abstract][Full Text] [Related]
36. A Chemical Acetylation-Based Mass Spectrometry Platform for Histone Methylation Profiling.
Zappacosta F; Wagner CD; Della Pietra A; Gerhart SV; Keenan K; Korenchuck S; Quinn CJ; Barbash O; McCabe MT; Annan RS
Mol Cell Proteomics; 2021; 20():100067. PubMed ID: 33775892
[TBL] [Abstract][Full Text] [Related]
37. Function and Mechanism of Novel Histone Posttranslational Modifications in Health and Disease.
Xu H; Wu M; Ma X; Huang W; Xu Y
Biomed Res Int; 2021; 2021():6635225. PubMed ID: 33763479
[TBL] [Abstract][Full Text] [Related]
38. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive proteomics and sialiomics of the anti-proliferative activity of safranal on triple negative MDA-MB-231 breast cancer cell lines.
Zarrineh M; Ashrafian S; Jensen P; Nawrocki A; Ansari AM; Rezadoost H; Ghassempour A; Larsen MR
J Proteomics; 2022 May; 259():104539. PubMed ID: 35240313
[TBL] [Abstract][Full Text] [Related]
40. Comparing and combining capillary electrophoresis electrospray ionization mass spectrometry and nano-liquid chromatography electrospray ionization mass spectrometry for the characterization of post-translationally modified histones.
Sarg B; Faserl K; Kremser L; Halfinger B; Sebastiano R; Lindner HH
Mol Cell Proteomics; 2013 Sep; 12(9):2640-56. PubMed ID: 23720761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
